e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
220.08
-4.05 (-1.81%)
Official Closing Price
Updated: 7:00 PM EST, Jan 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,722,918
Open
223.75
Bid (Size)
220.00 (200)
Ask (Size)
221.00 (200)
Prev. Close
224.13
Today's Range
219.00 - 225.12
52wk Range
164.39 - 244.81
Shares Outstanding
N/A
Dividend Yield
2.98%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Eli Lilly Solidifies Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences
January 09, 2026
In a move that underscores the tightening intersection between metabolic health and systemic inflammation, Eli Lilly and Company (NYSE: LLY) officially announced on January 7, 2026, its definitive...
Via
MarketMinute
2 Healthcare Stocks That Can Diversify a Tech-Heavy Portfolio
↗
January 09, 2026
Add some stability to your holdings with these healthcare giants.
Via
The Motley Fool
Topics
Economy
Intellectual Property
Lawsuit
Performance
YTD
-4.0%
-4.0%
1 Month
-2.3%
-2.3%
3 Month
-4.5%
-4.5%
6 Month
+14.4%
+14.4%
1 Year
+25.6%
+25.6%
More News
Read More
MoonLake Immunotherapeutics Surges as FDA "De-Risks" Sonelokimab, Reigniting Multi-Billion Dollar Takeover Speculation
January 09, 2026
Via
MarketMinute
Topics
Intellectual Property
The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader
January 08, 2026
Via
MarketMinute
Topics
Intellectual Property
1 Unpopular Stock That Deserves a Second Chance and 2 We Question
January 07, 2026
Via
StockStory
Ironwood Pharmaceuticals’ 2026 Guidance Shock Sparks a Major Re-Rating
↗
January 07, 2026
Via
MarketBeat
Revolution Medicines Stock Soars On Report Of AbbVie Takeover
↗
January 07, 2026
Via
Stocktwits
Red Spruce Capital Nets $3.7 Million by Dumping One-Third of BSCR Shares
↗
January 07, 2026
Via
The Motley Fool
Topics
Bonds
ETFs
Regulatory Compliance
3 Healthcare Stocks with Exciting Potential
January 06, 2026
Via
StockStory
Topics
Stocks
Top S&P500 movers in Monday's session
↗
January 05, 2026
Via
Chartmill
Flu Season's Here—This Dividend-Payer Controls the Shot Market
↗
January 05, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Death
Uncover the latest developments among S&P500 stocks in today's session.
↗
January 05, 2026
Via
Chartmill
26 Top Dividend Stocks to Buy and Hold in 2026
↗
January 05, 2026
Via
The Motley Fool
Topics
Intellectual Property
GH Research Stock Grabs Retail Spotlight Ahead Of FDA Update On Depression Treatment
↗
January 05, 2026
Via
Stocktwits
Take Warren Buffett's Advice: Don't Buy Any Stock in 2026 Unless It Passes This Test
↗
January 04, 2026
Via
The Motley Fool
Buying This Healthcare Stock Could Make You a Millionaire Retiree
↗
January 03, 2026
Via
The Motley Fool
Topics
Intellectual Property
Retirement
The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature
January 01, 2026
Via
PredictStreet
Topics
Economy
Lawsuit
World Trade
The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings
December 31, 2025
Via
MarketMinute
Topics
Economy
Intellectual Property
Law Enforcement
The Great Rebalancing: As Consumer Confidence Falters, Investors Retreat to the Safety of Large-Cap Value
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
AbbVie (ABBV): Buy, Sell, or Hold Post Q3 Earnings?
December 30, 2025
Via
StockStory
Topics
Stocks
Supply Chain
IGSB vs VCSH: Two Approaches to Short-Term Investment-Grade Credit
↗
December 30, 2025
Via
The Motley Fool
Topics
Bonds
ETFs
3 No-Brainer Dividend Stocks to Buy Right Now
↗
December 30, 2025
Via
The Motley Fool
Topics
ETFs
Retirement
The 2026 Income Fortress: Why Big Pharma is the Defensive Play of the New Year
December 30, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Why a New $3 Million Bet on Pathward Stock Signals Confidence in a Bank Posting $7.87 EPS
↗
December 28, 2025
Via
The Motley Fool
Is AbbVie a Buy, Sell, or Hold in 2026?
↗
December 27, 2025
Via
The Motley Fool
Topics
Intellectual Property
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 220.08
When was AbbVie last traded?
The last trade of AbbVie was at 01/09/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert